Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, January 9, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
MEDIPOST Secures $140 Million to Advance U.S. Phase III Stem Cell Trial
Life Sciences Times
-
January 9, 2026
Venture Capital
Carna Health Raises $8 Million to Expand Global Chronic Kidney Disease Screening Programs
Life Sciences Times
-
January 8, 2026
Venture Capital
Parabilis Medicines Raises $305 Million to Advance Zolucatetide and Helicon Platform
Life Sciences Times
-
January 8, 2026
Venture Capital
Vizgen Raises $48 Million to Accelerate Spatial Multi-Omics Growth
Life Sciences Times
-
January 8, 2026
Venture Capital
Corsera Health Raises $80 Million Series A and Begins First Clinical Trial
Life Sciences Times
-
January 7, 2026
Venture Capital
Kymera Therapeutics Closes Upsized $602 Million Public Offering, Underwriters Fully Exercise Option
Life Sciences Times
-
December 12, 2025
0
Biotech
Allonnia raises more than $20 million to accelerate deployment of materials biotechnology
Life Sciences Times
-
December 10, 2025
0
Venture Capital
EpilepsyGTx raises $33 million Series A to advance single-dose gene therapy for focal refractory epilepsy
Life Sciences Times
-
December 10, 2025
0
Venture Capital
Montagu and Kohlberg Agree to Acquire Teleflex Medical OEM for $1.5 Billion
Life Sciences Times
-
December 9, 2025
0
Venture Capital
Mirum Pharmaceuticals to Acquire Bluejay Therapeutics, Expanding Rare Disease Portfolio
Life Sciences Times
-
December 8, 2025
0
Medtech
Aptyx Expands With New Precision Extrusion Center of Excellence in Boston Medtech Corridor
Life Sciences Times
-
December 5, 2025
0
Venture Capital
Sempresto Acquires Alerje Autoinjector Platform to Advance Smartphone-Integrated Rescue Medications
Life Sciences Times
-
December 4, 2025
0
Venture Capital
Junevity Expands Seed Funding to $20 Million to Advance siRNA Cell Reprogramming Candidate for Metabolic Disease
Life Sciences Times
-
December 3, 2025
0
Venture Capital
TRIANA Biomedicines Closes $120 Million Series B to Advance Molecular Glue Degrader Programs
Life Sciences Times
-
December 3, 2025
0
Venture Capital
MindImmune Extends Series A to $30 Million to Advance Alzheimer’s Therapy and Names Isaac Stoner as CEO
Life Sciences Times
-
November 24, 2025
0
Venture Capital
Veolia to Acquire Clean Earth, Expanding U.S. Hazardous Waste Operations and Advancing Global Growth Strategy
Life Sciences Times
-
November 21, 2025
0
Venture Capital
Profluent Raises $106 Million to Scale Frontier AI Models for Programmable Biology
Life Sciences Times
-
November 19, 2025
0
1
2
3
...
110
Page 2 of 110
Most Read
Aurora Therapeutics Launches With $16 Million Seed Round to Scale Personalized Gene Editing for Rare Diseases
January 9, 2026
GC Therapeutics Names Kate Haviland Board Chair, Advances Cell Therapy Pipeline and Platform
January 9, 2026
MEDIPOST Secures $140 Million to Advance U.S. Phase III Stem Cell Trial
January 9, 2026
Prolytix Expands Thrombosis and Hemostasis Testing Capabilities With HRL Assay Acquisition
January 9, 2026